Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Bin Liu, Chaonan Lv, Jinxia Zhang, Ying Liu, Jing Sun, Xiaohua Cheng, Wenjing Mao, Yuanyuan Ma & Shiying Li. (2017) Effects of eldepryl on glial cell proliferation and activation in the substantia nigra and striatum in a rat model of Parkinson’s disease. Neurological Research 39:5, pages 459-467.
Read now
Read now
Articles from other publishers (15)
Xin Geng, Shipeng Li, Jinghui Li, Renli Qi, Lianmei Zhong & Hualin Yu. (2023) MDMA targets miR-124/MEKK3 via MALAT1 to promote Parkinson’s disease progression. Molecular Biology Reports 50:11, pages 8889-8899.
Crossref
Crossref
Asya Ozkizilcik, Aruna Sharma, Lianyuan Feng, Dafin F. Muresanu, Z. Ryan Tian, José Vicente Lafuente, Anca D. Buzoianu, Ala Nozari, Lars Wiklund & Hari Shanker Sharma. 2023. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors
83
121
.
Jingjing Shi, Chaoran Xia, Qiyuan Tian, Xiaoqun Zeng, Zhen Wu, Yuxing Guo & Daodong Pan. (2022) Untargeted metabolomics based on LC–MS to elucidate the mechanism underlying nitrite degradation by Limosilactobacillus fermentum RC4. LWT 163, pages 113414.
Crossref
Crossref
Alexandre Iarkov, Cristhian Mendoza & Valentina Echeverria. (2021) Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease. Frontiers in Neuroscience 15.
Crossref
Crossref
Benjamin E. Clarke, Rebecca San Gil, Jing Yip, Bernadett Kalmar & Linda Greensmith. (2019) Regional differences in the inflammatory and heat shock response in glia: implications for ALS. Cell Stress and Chaperones 24:5, pages 857-870.
Crossref
Crossref
Gerwyn Morris, Michael Maes, Michael Berk & Basant K. Puri. (2019) Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?. Metabolic Brain Disease 34:2, pages 385-415.
Crossref
Crossref
Neeraj Joshi & Sarika Singh. (2018) Updates on immunity and inflammation in Parkinson disease pathology. Journal of Neuroscience Research 96:3, pages 379-390.
Crossref
Crossref
Joy Chakraborty, Valentina Basso & Elena Ziviani. (2017) Post translational modification of Parkin. Biology Direct 12:1.
Crossref
Crossref
Camille B. Carroll & Richard K.H. Wyse. (2017) Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress. Journal of Parkinson's Disease 7:4, pages 545-568.
Crossref
Crossref
Yuan-Hao Chen, Eagle Yi-Kung Huang, Tung-Tai Kuo, Jonathan Miller, Yung-Hsiao Chiang & Barry J. Hoffer. (2017) Impact of Traumatic Brain Injury on Dopaminergic Transmission. Cell Transplantation 26:7, pages 1156-1168.
Crossref
Crossref
Melih Dagdeviren. 2017. Nitric Oxide Synthase - Simple Enzyme-Complex Roles. Nitric Oxide Synthase - Simple Enzyme-Complex Roles.
Mikael K. R. Engskog, Lisa Ersson, Jakob Haglöf, Torbjörn Arvidsson, Curt Pettersson & Eva Brittebo. (2017) β-N-Methylamino-l-alanine (BMAA) perturbs alanine, aspartate and glutamate metabolism pathways in human neuroblastoma cells as determined by metabolic profiling. Amino Acids 49:5, pages 905-919.
Crossref
Crossref
Michael H. Irwin, Walter H. Moos, Douglas V. Faller, Kosta Steliou & Carl A. Pinkert. (2016) Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases. Drug Development Research 77:3, pages 109-123.
Crossref
Crossref
Alla B. Salmina, Yulia K. Komleva, István A. Szijártó, Yana V. Gorina, Olga L. Lopatina, Galina E. Gertsog, Milos R. Filipovic & Maik Gollasch. (2015) H2S- and NO-Signaling Pathways in Alzheimer's Amyloid Vasculopathy: Synergism or Antagonism?. Frontiers in Physiology 6.
Crossref
Crossref
Carlos Wilson & Christian González-Billault. (2015) Regulation of cytoskeletal dynamics by redox signaling and oxidative stress: implications for neuronal development and trafficking. Frontiers in Cellular Neuroscience 9.
Crossref
Crossref